ISPOR issue panel focuses on addressing barriers to mHealth in cancer care

ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK.

The issue panel, "mHealth Among Clinicians and Patients in Cancer Care: How to Address the Digital Divide" [IP26], was moderated by Rosanna Tarricone, PhD, Bocconi University, Milan, Italy. Panelists included Maria Cucciniello, PhD, Bocconi University, Milan, Italy; Roma Maguire, PhD, MSc, University of Surrey, Glasgow, UK; and Nicola Scalzo, MSc, European Commission, Brussels, Belgium.

The use of mobile technologies in health care - mHealth - is surging in cancer care; however, its potential has yet to be fully explored. The panel reviewed mHealth's use in cancer care today, explored its potential, and discussed the barriers that currently prevent greater utilization. Maria Cucciniello, PhD discussed the results of an international survey on the use of mHealth that included the determinants that explain differences in uptake rates. Roma Maguire, PhD, MSc offered an overview of the potential mHealth has to empower patients and facilitate symptom management. Nicola Scalzo, MSc provided a regulatory perspective on mHealth and commented on how the newly adopted European Union regulation on medical devices may impact mHealth. ​

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
PM2.5 pollution linked to lung cancer shows sharp declines in the U.S. but not in China